切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - HIPK3 - 5-HT7 Receptors - 15-PGDH - Adenosine A2A Receptors

10 件产品

每页
清除全部
  1. Regadenoson
    B5904 Regadenoson
     1 Citation
    中文名: 类伽腺苷
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体激动剂
      ≥18.05 mg/mL
      insoluble in H2O
  2. SW033291
    A8709 SW033291
    Target: 15-PGDH
    Summary: 15-PGDH酶抑制剂
      ≥20.65 mg/mL
      insoluble in H2O
  3. SCH 58261
    B6995 SCH 58261
    Target: Adenosine A2A Receptors
    Summary: A2A腺苷受体竞争性拮抗剂
      ≥34.5 mg/mL
      insoluble in H2O
  4. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  5. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  6. Istradefylline (KW-6002)
    A8454 Istradefylline (KW-6002)
    中文名: 伊曲茶碱
    Target: Adenosine A2A Receptors
    Summary: 选择性A2A受体拮抗剂
      ≥8.78 mg/mL
      insoluble in H2O
  7. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  8. Tozadenant
    A3885 Tozadenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷2A受体拮抗剂
      ≥20.35 mg/mL
      insoluble in H2O
  9. Preladenant
    A3735 Preladenant
    Target: Adenosine A2A Receptors
    Summary: 腺苷A2A受体拮抗剂
      ≥7.3 mg/mL
      insoluble in H2O
  10. DMAT
    A3368 DMAT
     2 Citation
    Target: Pim|CK2|HIPK2|HIPK3
    Summary: CK2抑制剂
      ≥23.85 mg/mL
      insoluble in H2O

10 件产品

每页